Delivery Order SPE2DB20D1109-SPE2DB24FP45Y
Award Date
7/8/24
Potential Completion Date
7/29/24
Potential Value
$3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The $53,627.04 Firm Fixed Price Delivery Order contract is for the supply of RYANODEX 250 MG VIALS, a pharmaceutical product. The award has an ultimate completion date of August 5, 2024. AmerisourceBergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, with a significant Indefinite Delivery Contract (IDC) with...
This federal contract award, SPE2DX15D7068|SPE2DX24F2KPQ, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, Corporate Office Division. The contract, valued at $2,979.28, is for the delivery of RYANODEX 250 MG VIALS, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of August 21, 2024. Amerisourcebergen Drug Corp is a major supplier of...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $1,605.44 firm fixed-price delivery order is for the supply of RYANODEX 250 MG VIALS, with a completion date of July 18, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as...
This federal contract award, with the ID SPE2DB22D1017|SPE2DB25FE8MP, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,979.28 firm-fixed-price delivery order is for the supply of RYANODEX 250 MG VIALS, a critical medical commodity. The contract has an ultimate completion date of November 26, 2024 and was awarded on November 4, 2024. Amerisourcebergen holds a significant Indefinite...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Medical Supply Chain to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of RYANODEX 250 MG VIALS. The $1,489.64 firm fixed-price contract has a completion date of June 25, 2024. Amerisourcebergen, a major pharmaceutical distributor, leverages its extensive supply chain to fulfill government contracts, particularly for the Department of Defense (DoD) and Veterans Affairs (VA) healthcare systems. The...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp Corporate Office Division. The $8,937.84 firm-fixed-price delivery order is for the supply of RYANODEX 250 MG VIALS, a pharmaceutical product, with an ultimate completion date of September 26, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds several Indefinite Delivery Contracts (IDCs) with federal agencies, including a $999,999,999 IDC with DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The contract, valued at $22,344.60, is for the delivery of RYANODEX 250 MG VIALS to the agency. This is a firm fixed price delivery order contract with a completion date of March 6, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $4,468.92 firm fixed price delivery order is for the supply of RYANODEX 250 MG VIALS, a pharmaceutical product. The award has an ultimate completion date of April 11, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of RYANODEX 250 MG VIALS (4564821330) to the Defense Logistics Agency (DLA), a defense agency. The firm-fixed-price delivery order, valued at $2,979.28, has an ultimate completion date of June 26, 2024. Amerisourcebergen, a major pharmaceutical distribution company, has a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00...
This federal contract award, valued at $9,632.64, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RYANODEX 250 MG VIALS, a medical product, to support federal healthcare programs. The contract has a completion date of January 30, 2025 and is a Firm Fixed Price Delivery Order. No set-aside designation was used for this award. AmerisourceBergen holds a...